-
-
-
-
-
-
-
Zogenix (ZGNX) Tops Q1 EPS by 54c
-
-
-
-
-
-
-
Zogenix (ZGNX) Phase 3 Trial of FINTEPLA for Treatment of Lennox-Gastaut Syndrome Metes Primary Endpoint, Misses Secondary Endpont
-
-
-
-
-
-
-
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
12,348 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All